ESR1 and breast cancer: This PG was shown to enhance interleukin-8 (IL-8) production in BC cells in a manner independent of their ERα status and facilitate their growth, invasion, and migration by initiating downstream IL-8/CXCR2 signaling consisting of PI3K, Src, and Rac activation.